Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-07-12
2008-11-11
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S255050, C514S261100, C544S238000, C544S254000
Reexamination Certificate
active
07449465
ABSTRACT:
This invention concerns compounds of formulaN-oxides, pharmaceutically acceptable addition salts, quaternary amines and stereochemically isomeric forms thereof, their use, pharmaceutical compositions comprising them, and processes for their preparation.
REFERENCES:
patent: 6737085 (2004-05-01), Nishibe et al.
patent: 59062594 (1984-04-01), None
patent: 99/65897 (1999-12-01), None
patent: 00/62778 (2000-10-01), None
patent: 01/44246 (2001-06-01), None
patent: 02/04450 (2002-01-01), None
patent: 02/50073 (2002-06-01), None
patent: 02/055082 (2002-07-01), None
patent: 2004/018473 (2004-03-01), None
Dille et. al.; 1955; Journal of Organic Chemistry; vol. 20, p. 171-177.
King, et. al.; 2001; Platinum on Carbon; Encyclopedia of Reaageants for Organic Synthesis; pp. 1-6.
King, et. al.; 2001; Palladium on Carbon; Encyclopedia of Reaageants for Organic Synthesis; pp. 1-12.
Mills, et. al.; 2001; Hydrochloric Acid; Encyclopedia of Reaageants for Organic Synthesis; pp. 1-13.
Internal Medicine, 4th Edition, Editor-in-Chief Jay Stein, Chapters 71-72, pp. 699-715.
Schiaffino et. al., J.Behav.Med., 1995, 18(6), p. 536.
Cecil Textbook of Medicine, 21st Edition (2000), Goldman & Bennett (Editors), W.B. Saunders Company (Publisher), Chapter 198, pp. 1060-1074.
Dille, et. al., Journal of Organic Chemistry, (1955), 20, 171-7.
Buijnsters Peter Jacobus Johannes Antonius
Cooymans Ludwig Paul
Embrechts Werner Constant Johan
Freyne Eddy Jean Edgard
Love Christopher John
Janssen Pharmaceutica N.V.
Murray Jeffrey H
Wilson James O.
Woodcock & Washburn LLP
LandOfFree
Triazolopyrimidine derivatives as glycogen synthase kinase 3... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazolopyrimidine derivatives as glycogen synthase kinase 3..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazolopyrimidine derivatives as glycogen synthase kinase 3... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4023555